ASTROGEN BOOST BEYOND BOUNDARIES Trademark
Trademark Overview
On Monday, November 13, 2023, a trademark application was filed for ASTROGEN BOOST BEYOND BOUNDARIES with the United States Patent and Trademark Office. The USPTO has given the ASTROGEN BOOST BEYOND BOUNDARIES trademark a serial number of 79388640. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, November 4, 2024. This trademark is owned by Astrogen, inc.. The ASTROGEN BOOST BEYOND BOUNDARIES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Medicines for the treatment of intractable neurological disorders for human purposes; nutraceutical preparations for the treatment of intractable neurological disorders for therapeutic or medical purposes; pharmaceutical preparations for skin care for animals; adjuvants for use with vaccines; pharmaceutical preparations, namely, therapeutic drugs and agents for the treatment of intractable neurological disorders; pharmaceutical preparations for the treatment of central nervous system diseases; dietetic foods adapted for medical purposes; vitamin and mineral preparations for medical purposes; dietary supplements; pharmaceutical preparations for the treatment of intractable neurological disorders; pharmaceutical preparations for the prevention of intractable neurological disorders; medicinal herb extracts, other than essential oils; plant extracts for medical purposes, other than essential oils; herbal extracts for medical purposes, other than essential oils; pharmaceutical preparations ...
Pharmaceutical research services; bacteriological research; biotechnology research; biotechnology consulting services, namely, technical project management advisory services; drug discovery services; pharmaceutical drug development services for preventing and treating intractable disorders; scientific research in the field of pharmacy; technological advisory services in the fields of biotechnology; stem cell research services for medical research, treatment, and diagnosis
General Information
Serial Number | 79388640 |
Word Mark | ASTROGEN BOOST BEYOND BOUNDARIES |
Filing Date | Monday, November 13, 2023 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Monday, November 4, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, November 26, 2024 |
Trademark Statements
Description of Mark | The mark consists of a design of a small, red geometric person next to a larger, grey geometric person. To the right of the design is the wording "ASTROGEN" in black and below is the wording "BOOST BEYOND BOUNDARIES" in grey. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark. |
Goods and Services | Medicines for the treatment of intractable neurological disorders for human purposes; nutraceutical preparations for the treatment of intractable neurological disorders for therapeutic or medical purposes; pharmaceutical preparations for skin care for animals; adjuvants for use with vaccines; pharmaceutical preparations, namely, therapeutic drugs and agents for the treatment of intractable neurological disorders; pharmaceutical preparations for the treatment of central nervous system diseases; dietetic foods adapted for medical purposes; vitamin and mineral preparations for medical purposes; dietary supplements; pharmaceutical preparations for the treatment of intractable neurological disorders; pharmaceutical preparations for the prevention of intractable neurological disorders; medicinal herb extracts, other than essential oils; plant extracts for medical purposes, other than essential oils; herbal extracts for medical purposes, other than essential oils; pharmaceutical preparations for the central nervous system; pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting autonomic nervous system; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of digestive diseases |
Indication of Colors claimed | The color(s) red, black, and grey is/are claimed as a feature of the mark. |
Goods and Services | Pharmaceutical research services; bacteriological research; biotechnology research; biotechnology consulting services, namely, technical project management advisory services; drug discovery services; pharmaceutical drug development services for preventing and treating intractable disorders; scientific research in the field of pharmacy; technological advisory services in the fields of biotechnology; stem cell research services for medical research, treatment, and diagnosis |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 12, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 12, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Astrogen, inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | KR |
Trademark Events
Event Date | Event Description |
Friday, February 9, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Monday, February 12, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, February 16, 2024 | APPLICATION FILING RECEIPT MAILED |
Wednesday, June 19, 2024 | ASSIGNED TO EXAMINER |
Monday, June 24, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, June 25, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, July 16, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Tuesday, July 16, 2024 | REFUSAL PROCESSED BY MPU |
Tuesday, October 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, October 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, October 22, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Sunday, August 4, 2024 | REFUSAL PROCESSED BY IB |
Tuesday, October 29, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, October 29, 2024 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, October 29, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, October 29, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Tuesday, October 29, 2024 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, November 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |